CDSCO Panel Accepts Glenmark's Apremilast Trial Report, Seeks 2-Year PSUR Data Parthika Patel10 Aug 2025 1:00 PM ISTNew Delhi: Glenmark Pharmaceuticals Limited has received approval from the Subject Expert Committee (SEC), functioning under the Central Drugs...
Sun Pharma Gets CDSCO Panel Nod For Alfuzosin-Tadalafil FDC Post-Marketing Study Dr. Divya Colin10 Aug 2025 12:30 PM ISTNew Delhi: Drugmaker Sun Pharmaceutical Laboratories Ltd has been granted conditional approval by the Subject Expert Committee (SEC), under the...
Abiogenesis Clinpharm To Conduct Phase III Trial of UTI Drug Phenazopyridine Susmita Roy10 Aug 2025 11:15 AM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drugs Standard Control Organisation (CDSCO), has granted approval to...
Eli Lilly Gets CDSCO Panel Nod for Ixekizumab Safety Label Update Dr. Divya Colin9 Aug 2025 12:30 PM ISTNew Delhi: Eli Lilly and Company (India) Pvt Ltd has secured regulatory clearance from the Subject Expert Committee (SEC) under the Central Drugs...
CDSCO Panel Approves New Indications for Novo Nordisk's Semaglutide, Mandates PMS Study Susmita Roy9 Aug 2025 12:18 PM ISTNew Delhi: Recommending to conduct post marketing surveillance (PMS) study in India, the Subject Expert Committee (SEC) functional under the Central...
Intas Pharma Gets Expert Panel Nod For PMS Data On Tofacitinib Ointment In Atopic Dermatitis Parthika Patel9 Aug 2025 11:30 AM ISTNew Delhi: Intas Pharma has received approval from the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO)...
Abbott to Conduct BE Study for Carbimazole 15 mg, Trial Waiver Granted In India Parthika Patel8 Aug 2025 2:34 PM ISTNew Delhi: Abbott Healthcare Pvt. Ltd has received the green signal from the Subject Expert Committee (SEC) under the Central Drugs Standard Control...
Pfizer Gets Expert Panel Nod to Update Etanercept Pre-Filled Injection Label Susmita Roy8 Aug 2025 2:08 PM ISTNew Delhi: Following a thorough review of post-marketing safety data, published literature, and clinical trial findings, the Subject Expert Committee...
CDSCO Committee Asks Elevate Scientific To Prove Back Pain Gel In Indian Trial Susmita Roy7 Aug 2025 11:55 PM ISTNew Delhi: With an aim to demonstrate the safety and efficacy on lower back pain, the Subject Expert Committee (SEC) functioning under the Central...
Dr Reddy's Gets CDSCO Panel Approval To Begin Phase III Trial of Tapinarof Cream Parthika Patel7 Aug 2025 11:41 PM ISTNew Delhi: Dr. Reddy's Laboratories Limited has received approval from the Subject Expert Committee (SEC) under CDSCO to conduct a Phase III clinical...
No Ban on Paracetamol, Says Govt; 156 Drug Combos Axed Over Safety Concerns Farhat Nasim7 Aug 2025 7:41 PM ISTNew Delhi: While 156 fixed-dose combinations (FDCs), including some involving Paracetamol, have been banned in public interest, the standalone drug...
No Waiver for Faricimab: CDSCO Panel Asks Roche to Conduct Phase III Trial in India Parthika Patel6 Aug 2025 3:34 PM ISTNew Delhi: Roche Products (India) Pvt Ltd has been directed by the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation...
